Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

TCTMD’s Top 10 Most Popular Stories for September 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2022

October 03, 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

September 07, 2022

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

September 25, 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

May 17, 2018

TCTMD’s Top 10 Most Popular Stories for April 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2018

April 30, 2018

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On, With Hotly Anticipated Trials

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

August 18, 2017

News Daily News

New Percutaneous Device Reduces Resistant Hypertension in Small Trial

February 03, 2015

News Daily News

Endovascular Renal Nerve Ablation Safely Reduces BP During Exercise

August 29, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.